Table 3:

Relative Risk of Death by Blood Pressure Components (N=10,336)

	SBP/DBP						Pulse Pressure
	With baseline cardiovascular conditions (N=2,973)			Without baseline cardiovascular conditions (N=7,363)			With baseline cardiovascular conditions (N=2,973)			Without baseline cardiovascular conditions (N=7,363)
	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p
Blood Pressure Groups (SBP/DBP)
Normal/Normal (reference)
Low/Low or Low/Normal	2.34	1.45, 3.80	<.001	1.41	0.70, 2.84	0.335
Normal/Low	1.45	1.17, 1.81	<.001	1J0	0.97,1.75	0.080
Normal High	1.20	0.73, 1.98	0.466	1.19	0.83, 1.70	0.338
Hick/Normal	1.11	0.97, 1.27	0.115	1.09	0.96, 1.23	0.207
High/High	1.03	0.86, 1.23	0.781	1.21	1.06, 1.40	0.007
Pulse pressure groups
Normal (reference)
Low							1.19	0.98, 1.43	0.074	0.94	0.79, 1.12	0.473
High							1.12	0.99, 1.26	0.074	1.08	0.97, 1.21	0.175
Baseline age	1.08	1.07, 1.09	<.001	1.10	1.09, 1.11	<.001	1.08	1.08, 1.09	<.001	1.10	1.09, 1.11	<.001
Female	0.93	0.82, 1.05	0.227	0.75	0.67, 0.83	<.001	0.91	0.81, 1.03	0.129	0.76	0.68, 0.84	<.001
Baseline BMI	0.99	0.98, 1.00	0.190	0.98	0.97, 0.99	<.001	0.99	0.98, 1.00	0.151	0.98	0.97, 0.99	<.001
Baseline total cholesterol	1.00	1.00, 1.00	0.608	1.00	1.00, 1.00	0.512	1.00	1.00, 1.00	0.396	1.00	1.00, 1.00	0.547
Baseline HbAlc	1.16	1.12, 1.23	<.001	1.19	1.13, 1.24	<.001	1.17	1.11, 1.23	<.001	1.18	1.13, 1.24	<.001
Taking antihvpertensive medication at baseline	1.19	1.04, 1.35	0.010	1.08	0.97, 1.20	0.162	1.17	1.03, 1.33	0.020	1.07	0.96, 1.18	0.233
Lifelong smoking pack years	1.01	1.01, 1.01	<.001	1.01	1.01, 1.02	<.001	1.01	1.01, 1.01	<.001	1.01	1.01, 1.02	<.001

SBP: Systolic Blood Pressure

DBP: Diastolic Blood Pressure

HR: Hazard Ratio

CI: Confidence Interval